Allianz SE Makes New $25.80 Million Investment in UnitedHealth Group Incorporated (NYSE:UNH)

Allianz SE purchased a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 50,813 shares of the healthcare conglomerate's stock, valued at approximately $25,802,000. UnitedHealth Group makes up about 0.7% of Allianz SE's investment portfolio, making the stock its 26th largest position.

A number of other hedge funds and other institutional investors have also recently modified their holdings of UNH. Howard Capital Management Group LLC purchased a new position in UnitedHealth Group in the third quarter valued at approximately $341,000. Principal Financial Group Inc. grew its stake in shares of UnitedHealth Group by 11.3% during the 3rd quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate's stock worth $1,039,933,000 after acquiring an additional 180,479 shares during the period. Kingfisher Capital LLC lifted its holdings in UnitedHealth Group by 1.2% during the third quarter. Kingfisher Capital LLC now owns 2,923 shares of the healthcare conglomerate's stock valued at $1,709,000 after purchasing an additional 36 shares during the last quarter. Captrust Financial Advisors lifted its stake in shares of UnitedHealth Group by 0.9% during the 3rd quarter. Captrust Financial Advisors now owns 210,464 shares of the healthcare conglomerate's stock valued at $123,054,000 after buying an additional 1,789 shares in the last quarter. Finally, Fred Alger Management LLC lifted its position in shares of UnitedHealth Group by 91.9% during the third quarter. Fred Alger Management LLC now owns 199,460 shares of the healthcare conglomerate's stock worth $116,620,000 after acquiring an additional 95,503 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

Remove Ads

Insiders Place Their Bets

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the company's stock in a transaction that occurred on Friday, January 17th. The stock was purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares in the company, valued at $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.33% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several research analysts have commented on UNH shares. KeyCorp reaffirmed an "overweight" rating and set a $650.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. HSBC raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price target for the company in a report on Friday, January 10th. Oppenheimer lifted their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the company an "outperform" rating in a research note on Friday, December 6th. Truist Financial dropped their price target on UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating for the company in a research report on Monday, January 6th. Finally, Wells Fargo & Company dropped their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating for the company in a research report on Tuesday, January 28th. Twenty analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group has an average rating of "Buy" and a consensus target price of $629.32.

UnitedHealth Group Stock Up 1.6 %

Shares of UNH stock traded up $8.44 during mid-day trading on Monday, hitting $524.48. The company's stock had a trading volume of 5,024,239 shares, compared to its average volume of 4,764,878. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The business has a 50-day moving average price of $508.81 and a 200 day moving average price of $543.92. The stock has a market cap of $479.75 billion, a price-to-earnings ratio of 33.84, a PEG ratio of 1.37 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts' consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same period in the previous year, the business posted $5.83 earnings per share. The business's revenue for the quarter was up 6.8% on a year-over-year basis. Research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.60%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's dividend payout ratio (DPR) is currently 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.